NEW YORK (
) -- Shares of
) were gapping up Thursday morning with an open price 13.7% higher than Wednesday's closing price. The stock closed at $2.27 Wednesday and opened today's trading at $2.58.
The average volume for Neoprobe has been 1.6 million shares per day over the past 30 days. Neoprobe has a market cap of $246.2 million and is part of the
industry. Shares are up 10.2% year to date as of the close of trading on Wednesday.
Neoprobe Corporation, a biomedical company, engages in the development and commercialization of surgical and diagnostic oncology products that enhance patient treatment by meeting the critical decision making needs of physicians in the United States and internationally.
TheStreet Ratings rates Neoprobe as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full
Get more investment ideas from our
Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from